Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Viagene
AddedMar 20, 2024
UpdatedJun 18, 2026
Viagene

Viagene

Seed

Innovative software company in Lutz, FL, advancing life science research globally.

HQ
Lutz, FL, US
Overview
Compare
Fundraising
Employees
Website

Viagene, founded by experienced researchers in Lutz, Florida, is dedicated to advancing molecular and cell biology research globally. The company offers innovative and practical products and services, including EMSA/GEL Shift Kits, custom EMSA probes with biotin or fluorophore labeling, and tools for identifying RNA/DNA-binding proteins. Viagene's core mission is to provide inventive methods and new goods to support life science research, making it accessible and efficient for scientists worldwide.

Notable affiliated individuals include leading researchers in the biological sciences who have contributed to numerous published articles. Viagene has achieved significant milestones in the life sciences sector, particularly in developing non-radioactive EMSA kits and advanced transfection technologies. The company's impact is reflected in its widespread adoption by researchers and institutions globally, enhancing the efficiency and effectiveness of molecular and cell biology research.

Viagene - Similar Companies

Genetix Fusion logo

Genetix Fusion

Virogenomics logo

Virogenomics

virogenomics.com

Zymo Research logo

Zymo Research

zymoresearch.com

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Vivebio logo

Vivebio

Innovative Genetics logo

Innovative Genetics

Vizma Life Sciences logo

Vizma Life Sciences

Epigentek Group logo

Epigentek Group

epigentek.com

Intact Genomics logo

Intact Genomics

intactgenomics.com

Topogen logo

Topogen

topogen.com

Attogene logo

Attogene

attogene.com

Fluidigm logo

Fluidigm

standardbio.com

Enzium logo

Enzium

enziumlabs.com

Evizia logo

Evizia

eviziadx.com

Vitra Bioscience logo

Vitra Bioscience

Viagene - Quick Facts

Who are Viagene's competitors?

Companies similar to Viagene include Genetix Fusion, Virogenomics, Zymo Research and Bioinformatics.

Where is Viagene's headquarters located?

Viagene's headquarters is located in Lutz, FL, US.

When was Viagene's last funding round?

Viagene's most recent funding round was for $1M (USD) in December 1987.

How much has Viagene raised to-date?

As of Dec 9, 1987, Viagene has raised a total of $1M (USD).

How many employees does Viagene have?

Viagene has 6 employees as of Feb 4, 2024.

Viagene - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • EMSA Kits
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software